학술논문
Results from Phase 1/2 Trial of Tagraxofusp in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Document Type
Abstract
Author
Source
In Blood 13 November 2019 134 Supplement 1:3145-3145
Subject
Language
ISSN
0006-4971